Indivior Plc specializes in creating prescription drugs aimed at treating opioid dependence and related disorders. Its main products include SUBLOCADE, a subcutaneous injection, and SUBOXONE and SUBUTEX, both sublingual tablets designed to manage opioid use disorder, addiction, and schizophrenia. With a presence in around 40 countries, Indivior focuses on improving the lives of those struggling with these conditions. Founded in 2014 and based in North Chesterfield, Virginia, the company also collaborates with Addex Therapeutics Ltd to expand its treatment offerings.
Howard Marks just filed five equity positions that look nothing like a bull-market portfolio, and every one has moved sharply since he bought. The question now is whether his thesis still holds…
